# INTERVIEW: Deltex Medical Group Plc Looking pretty good

- Link: https://www.directorstalkinterviews.com/interview-deltex-medical-group-plc-looking-pretty-good/412722492
- Published: 2017-01-27T10:38:03+00:00
- Author: Giles Arbor

**Deltex Medical Group Plc** (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk
about the benefits of the South Korean health authorities decision to increase the
range of medical conditions for which they will reimburse the cost of using ODM.
Ewan explains what this means for Deltex, other international markets and his thoughts
on how 2017 will play out.

Deltex Medical Group Plc manufactures and markets haemodynamic monitoring technologies.
The company’s ODM is the only technology to measure continuously blood flow in the
central circulation in real time. Minimally invasive, easy to set up and quick to
focus, the technology generates a low-frequency ultrasound signal, which is highly
sensitive to changes in flow and measures them immediately. Deltex has been the 
only company in the enhanced haemodynamic space to build a robust and credible evidence
base proving the clinical and economic benefits of its core technology, ODM. Randomised,
controlled trials using Doppler have demonstrated that early fluid management intervention
will reduce post-operative complications, reduce intensive care admissions, and 
reduce the length of hospital stay.

Share on: